Merck has shared data from the pivotal Phase 3 trial evaluating the subcutaneous administration of pembrolizumab together ...

Novo Nordisk has entered into an exclusive license agreement with Lexicon Pharmaceuticals Inc. for LX9851, a first-in-class, ...

Curium Pharma, a developer, manufacturer, and distributor of nuclear medicine, has acquired Eczacıbaşı-Monrol Nuclear ...

Balancing safety and convenience, innovative stick pack designs offer a patient-centric solution for on-the-go dosage forms.

How innovation, advanced manufacturing, and expertise drive success in the evolving CDMO and generics landscape.

Linearis has inaugurated a new laboratory in the greater Quebec City region and introduced its high-throughput metabolomics ...

BioDuro has opened a new lab in Shanghai, China for highly potent compound synthesis at the hundred-gram scale.

The FDA has approved GSK’s Blujepa for the treatment of female adults and pediatric patients with uncomplicated urinary tract ...

National Resilience Inc., a technology-focused biomanufacturing company, is initiating the next phase of its growth in the ...

Navigating compliance challenges and technology solutions under DSCSA.

The FDA has granted fast track designation to Sanofi’s mRNA vaccine candidate for the prevention of chlamydia infection.

Investment includes agreements with Harbour BioMed, Syneron Bio and BioKangtai
.